TY - JOUR
T1 - Melt Electrowriting of Polyhydroxyalkanoates for Enzymatically Degradable Scaffolds
AU - Gładysz, Magdalena Z.
AU - Ubels, Didi
AU - Koch, Marcus
AU - Amirsadeghi, Armin
AU - Alleblas, Frederique
AU - van Vliet, Sander
AU - Kamperman, Marleen
AU - Siebring, Jeroen
AU - Nagelkerke, Anika
AU - Włodarczyk-Biegun, Małgorzata K.
N1 - Publisher Copyright:
© 2024 The Author(s). Advanced Healthcare Materials published by Wiley-VCH GmbH.
PY - 2025/3/3
Y1 - 2025/3/3
N2 - Melt electrowriting (MEW) enables precise scaffold fabrication for biomedical applications. With a limited number of processable materials with short and tunable degradation times, polyhydroxyalkanoates (PHAs) present an interesting option. Here, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and a blend of PHBV and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (PHBV+P34HB) are successfully melt electrowritten into scaffolds with various architectures. PHBV+P34HB exhibits greater thermal stability, making it a superior printing material compared to PHBV in MEW. The PHBV+P34HB scaffolds subjected to enzymatic degradation show tunable degradation times, governed by enzyme dilution, incubation time, and scaffold surface area. PHBV+P34HB scaffolds seeded with human dermal fibroblasts (HDFs), demonstrate enhanced cell adherence, proliferation, and spreading. The HDFs, when exposed to the enzyme solutions and enzymatic degradation residues, show good viability and proliferation rates. Additionally, HDFs grown on enzymatically pre-incubated scaffolds do not show any difference in behavior compared those grown on control scaffolds. It is concluded that PHAs, as biobased materials with enzymatically tunable degradability rates, are an important addition to the already limited set of materials available for MEW technology.
AB - Melt electrowriting (MEW) enables precise scaffold fabrication for biomedical applications. With a limited number of processable materials with short and tunable degradation times, polyhydroxyalkanoates (PHAs) present an interesting option. Here, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and a blend of PHBV and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (PHBV+P34HB) are successfully melt electrowritten into scaffolds with various architectures. PHBV+P34HB exhibits greater thermal stability, making it a superior printing material compared to PHBV in MEW. The PHBV+P34HB scaffolds subjected to enzymatic degradation show tunable degradation times, governed by enzyme dilution, incubation time, and scaffold surface area. PHBV+P34HB scaffolds seeded with human dermal fibroblasts (HDFs), demonstrate enhanced cell adherence, proliferation, and spreading. The HDFs, when exposed to the enzyme solutions and enzymatic degradation residues, show good viability and proliferation rates. Additionally, HDFs grown on enzymatically pre-incubated scaffolds do not show any difference in behavior compared those grown on control scaffolds. It is concluded that PHAs, as biobased materials with enzymatically tunable degradability rates, are an important addition to the already limited set of materials available for MEW technology.
KW - 3D printing
KW - biodegradable polymers
KW - P34HB
KW - poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
KW - poly(3-hydroxybutyrate-co-4-hydroxybutyrate
UR - http://www.scopus.com/inward/record.url?scp=85208793553&partnerID=8YFLogxK
U2 - 10.1002/adhm.202401504
DO - 10.1002/adhm.202401504
M3 - Article
AN - SCOPUS:85208793553
SN - 2192-2640
VL - 14
JO - Advanced healthcare materials
JF - Advanced healthcare materials
IS - 6
M1 - 2401504
ER -